The core activity of Swyssi is the development and manufacture of complex generic drugs, as well as the life cycle extension of established, off-patent medicines, particularly in the areas of cardiology, diabetes, central nervous system and respiratory diseases.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Regulatory approvals for prescription medicines, including rosuvastatin, candesartan combinations, amlodipine combinations, rivaroxaban, antibiotics, sitagliptin/metformin and ticagrelor products.
Complex Generic Drug Products
Complex generic drug products developed and manufactured in GLP- and cGMP-compliant processes, including formulation, characterization, manufacturing and bioequivalence support.
Life-cycle extension of mature prescription pharmaceuticals
Life-cycle extension of divested mature prescription pharmaceuticals, supporting established brands in cardiovascular, diabetes, CNS and respiratory fields.
Pharmacovigilance
Pharmacovigilance for Swyssi products, including safety information, adverse-effect reporting and case handling for patients and healthcare professionals.
Patient Awareness Programs
Patient awareness programs for patients and other audiences, focused on medicines, long-term chronic diseases and health promotion.
Physicians Continuous Education and Advanced Specialization
Continuous education and advanced specialization activities for physicians, alongside scientific and medical knowledge-sharing formats.
Scientific Symposia and Congresses
Scientific symposia and congresses for healthcare professionals and other stakeholders, led by external experts and opinion leaders.
Comparisons
Swyssi PMFS AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Swyssi PMFS AG by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Swyssi PMFS AG has claimed this profile, we'll publish editorial articles and case studies here together.